Novel Intervention for Drug Use and HIV Risk among Anxiety Sensitive Heroin Users
针对焦虑敏感海洛因使用者吸毒和艾滋病毒风险的新干预措施
基本信息
- 批准号:7554085
- 负责人:
- 金额:$ 37.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAccountingAcquired Immunodeficiency SyndromeAddressAlcohol or Other Drugs useAmericanAnxietyAreaArousalAttitudeBasic ScienceBehaviorBeliefCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicalCognitiveCombined Modality TherapyComorbidityContractsDataDropoutDropsDrug usageEducational process of instructingEffectivenessEsthesiaEventExerciseFrightGoalsHIVHIV InfectionsHeroinHeroin UsersHypersensitivityIndividualIndividual DifferencesInjection of therapeutic agentInterventionKnowledgeLifeLinkMediator of activation proteinMinorityModelingMoodsNeedlesNondirective TherapyOutcomeOutcome MeasurePatientsPatternPopulationPovertyPrevalenceProcessProtocols documentationPsychological ModelsPublic HealthRandomized Controlled Clinical TrialsRandomized Controlled TrialsRelapseRelative (related person)RelianceResearchResidential TreatmentRiskRisk BehaviorsSafetySex BehaviorStagingStructureSymptomsTestingTreatment outcomeUnited States Substance Abuse and Mental Health Services AdministrationWorkactive controlbasebodily sensationbrief interventioncopingcravinghigh risk sexual behaviorimprovedinner citynovelpreventpsychologicsex riskskillssocialtherapy designtherapy developmenttransmission processtreatment center
项目摘要
More than 850,000 Americans are currently living with AIDS and an estimated 40,000 continue to contract HIV
each year (CDC, 2004). Minority individuals living in urban and poverty-stricken areas who engage in injection
heroin use are particularly at risk for HIV infection (Chitwood et aI., 2000; De Rossi et aI., 1988; SAMHSA,
2003). These findings suggest the importance of developing treatments focused on helping individuals achieve
abstinence from injection heroin use, especially within inner-city minority popUlations. However, inner-city
minorities are less likely to have access to longer-term substance use treatment (Bernstein et aI., 2005), and
within residential treatment centers, the likelihood of drop-out and relapse to substance use among injection
heroin users is strikingly high (Manu et aI., 1994). Therefore, there is a need for targeted, brief interventions
that can be conducted as an adjunct to substance use treatment to reduce vulnerability for treatment drop-out
and relapse to substance use, reducing risk for further injection drug use and HIV infection or transmission.
Building from contemporary models of psychological vulnerability (Barlow, 2002), there is conceptual and
robust empirical reason to explore cognitive factors reflecting a hypersensitivity to aversive events in order to
better understand the factors that contribute to treatment dropout and relapse to substance use among heroin
users (Brown et aI., 2005). One such cognitive vulnerability that holds promise is anxiety sensitivity (AS). AS, a
relative stable individual difference characteristic representing the tendency to fear anxiety-related symptoms
due to the belief that these symptoms will have negative consequences (Reiss, 1991), has recently been linked
to heroin use (Lejuez et aI., 2006) and has been found to significantly and uniquely predict treatment drop-out
among heroin users (Lejuez et aI., 2007). Our group has subsequently developed an exposure-based
individual intervention specifically tailored to inner-city heroin users with heightened AS - the Anxiety
Sensitivity Treatment for Heroin Users (ASTH; Tull et aI., 2007). Pilot data indicate the feasibility of the
treatment with patients evidencing reduced AS and heroin cravings. Additionally, if the treatment is successful,
there is a counterintuitive potential for increased HIV risk through sexual contact resulting from a reduction in
heroin use and/or anxiety. Therefore, we propose to utilize an integrated treatment combining ASTH with
Healthy Relationships (HR; Kalichman et aI., 2001), a targeted intervention designed to prevent high risk
sexual behavior. The combined intervention (ASTH+HR) is now structured to reduce risk for HIV
infection/transmission by (a) promoting heroin abstinence by reducing AS, and (b) preventing engagement in
risky sexual behaviors using a social cognitive approach aimed at increasing one's understanding of
interpersonal/intimate relationships and potential for risky sexual behaviors in those relationships, combined
with skill building to help the individual more effectively cope and remain sexually safe in those situations. We
also collected pilot data to establish the safety, feasibility, and acceptability of this combined intervention. The
objective of the present proposal is to provide a two year Stage 1b randomized control trial of 60 patients
receiving standard residential substance use treatment comparing ASTH combined with modules from a
modified Healthy Relationships (HR; a brief intervention designed to reduce risky sex behaviors; Kalichman et
aI., 2001) to nondirective therapy (NT+HR), with a focus on the substance use outcomes of treatment drop-out
from the residential treatment and relapse following the residential treatment across 3 months, as well as
engagement in HIV-risk behaviors including injection drug use and risky sexual behavior across this period.
目前有超过85万美国人居住在艾滋病中,估计有40,000人继续签约艾滋病毒
每年(CDC,2004年)。居住在城市和贫困地区的少数民族个人
海洛因使用尤其有艾滋病毒感染的风险(Chitwood et ai。,2000; de Rossi et ai。,1988; Samhsa,
2003)。这些发现表明,开发旨在帮助个人实现的治疗的重要性
禁止注射海洛因使用,尤其是在城市少数群体中。但是,内城
少数族裔不太可能获得长期药物使用治疗(Bernstein et ai。,2005),并且
在住宅治疗中心中,辍学的可能性和在注射中复发到药物的可能性
海洛因使用者非常高(Manu et ai。,1994)。因此,需要进行针对性的简短干预措施
可以作为药物使用治疗的辅助性进行,以减少治疗辍学的脆弱性
并复发到药物使用,降低了进一步注射药物使用和HIV感染或传播的风险。
从当代心理脆弱性模型建立(Barlow,2002),有概念性和
强大的经验理由探索认知因素,反映出对厌恶事件的超敏反应
更好地了解有助于治疗辍学和对海洛因物质使用的因素
用户(Brown et ai。,2005)。持有承诺的一种认知脆弱性是焦虑敏感性(AS)。 AS,
相对稳定的个体差异特征,代表了害怕焦虑相关症状的趋势
由于相信这些症状会带来负面后果(Reiss,1991),最近已连接
使用海洛因(Lejuez et ai。,2006),并被发现可以显着预测治疗的辍学
在海洛因使用者中(Lejuez et ai。,2007)。我们的小组随后开发了基于曝光的
专门针对城市内海洛因使用者量身定制的个人干预措施,焦虑症
海洛因使用者的敏感性治疗(Asth; Tull et ai。,2007)。试验数据表明
证明患者的治疗降低了AS和海洛因的渴望。此外,如果治疗成功,
通过减少性接触而导致的性接触有违反直觉的潜力
海洛因使用和/或焦虑。因此,我们建议利用将哮喘与
健康关系(HR; Kalichman et ai。,2001),旨在防止高风险的有针对性干预措施
性行为。现在结构的干预措施(ASTH+HR)的结构是降低艾滋病毒的风险
通过(a)通过减少AS来促进海洛因禁欲的感染/传播,(b)防止参与
使用社会认知方法的有风险的性行为,旨在提高人们对
人际关系/亲密关系和在这些关系中有风险的性行为的潜力,结合在一起
通过技能建设来帮助个人更有效地应对并在这种情况下保持性安全。我们
还收集了飞行员数据,以确定此组合干预措施的安全性,可行性和可接受性。这
本提案的目的是为60名患者提供两年的1B随机对照试验
接受标准的住宅物质使用治疗,比较ASTH与来自A的模块相比
修改了健康的关系(人力资源;旨在减少风险性行为的短暂干预; Kalichman ET
AI。,2001年)至非指导疗法(NT+HR),重点是治疗辍学结果
从住院治疗和住宅治疗后3个月的复发以及
在此期间,参与包括注射药物使用和风险性行为在内的艾滋病毒风险行为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carl W Lejuez其他文献
Carl W Lejuez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carl W Lejuez', 18)}}的其他基金
Novel Assessment of Maternal Distress Tolerance Underlying Substance Use Relapse
对药物滥用复发的孕产妇痛苦耐受性的新评估
- 批准号:
8358284 - 财政年份:2012
- 资助金额:
$ 37.11万 - 项目类别:
Novel Assessment of Maternal Distress Tolerance Underlying Substance Use Relapse
对药物滥用复发的孕产妇痛苦耐受性的新评估
- 批准号:
8514554 - 财政年份:2012
- 资助金额:
$ 37.11万 - 项目类别:
Integration of Basic Neuroscience Research into Addiction Treatment Development
将基础神经科学研究融入成瘾治疗开发
- 批准号:
8109945 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Integration of Basic Neuroscience Research into Addiction Treatment Development
将基础神经科学研究融入成瘾治疗开发
- 批准号:
7854619 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Integration of Basic Neuroscience Research into Addiction Treatment Development
将基础神经科学研究融入成瘾治疗开发
- 批准号:
8819275 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Integration of Basic Neuroscience Research into Addiction Treatment Development
将基础神经科学研究融入成瘾治疗开发
- 批准号:
8494020 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Integration of Basic Neuroscience Research into Addiction Treatment Development
将基础神经科学研究融入成瘾治疗开发
- 批准号:
8688208 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Integration of Basic Neuroscience Research into Addiction Treatment Development
将基础神经科学研究融入成瘾治疗开发
- 批准号:
8287679 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Behavioral Measurement of Negative Reinforcement in Adolescent Alcohol Use/Abuse
青少年酒精使用/滥用的负强化行为测量
- 批准号:
7804571 - 财政年份:2009
- 资助金额:
$ 37.11万 - 项目类别:
Novel Intervention for Drug Use and HIV Risk among Anxiety Sensitive Heroin Users
针对焦虑敏感海洛因使用者吸毒和艾滋病毒风险的新干预措施
- 批准号:
7929523 - 财政年份:2009
- 资助金额:
$ 37.11万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
SCIENTIFIC, TECHNICAL AND OTHER PROFESSIONAL SUPPORT SERVICES (STOPS)
科学、技术和其他专业支持服务(停止)
- 批准号:
10291118 - 财政年份:2018
- 资助金额:
$ 37.11万 - 项目类别:
Life Course Investigation of People Who Inject Drugs
注射吸毒者生命历程调查
- 批准号:
9031757 - 财政年份:2015
- 资助金额:
$ 37.11万 - 项目类别:
Life Course Investigation of People Who Inject Drugs
注射吸毒者生命历程调查
- 批准号:
8928767 - 财政年份:2015
- 资助金额:
$ 37.11万 - 项目类别:
Administrative supplement to Lifecourse study for replacement freezer
更换冰箱生命历程研究的行政补充
- 批准号:
9127424 - 财政年份:2015
- 资助金额:
$ 37.11万 - 项目类别:
Comparison of supportive housing models for HIV+ and at-risk chronically homeless
针对艾滋病毒和高危长期无家可归者的支持性住房模式比较
- 批准号:
8866382 - 财政年份:2014
- 资助金额:
$ 37.11万 - 项目类别: